http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-117270-C2
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-535 |
| filingDate | 2016-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7bf8d368f533707ee6abfb85f9a997d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01a759cf101d29ce62016229b5081679 |
| publicationDate | 2018-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | UA-117270-C2 |
| titleOfInvention | METHOD OF FORECASTING FORMATION OF CHRONIC OBSTRUCTIVE LUNG DISEASE IN PATIENTS WITH HYPERTONIC DISEASE |
| abstract | The invention relates to medicine and relates to a method for predicting the formation of COPD in patients with GC, which includes the determination in the blood of the patient vasoactive peptides - peptidyl-dipeptidase and carboxypeptidase-N, which is determined by spectrofluorimetric method, kallikreptin, determined by the method of enzyme-linked immunosorbent assay, vasoactive hormone - aldosterone, determined by the method of enzyme-linked immunosorbent assay, and neurotransmitter - norepinephrine, which determines the fluorimetric method, and at levels of peptidyl dipeptidase - 28,94 ± 1,72 nmol / ml · min, carboxypeptidase-N - 1,76 ± 0,18 μmol GAK / ml · min, vasoactive intestinal peptide - 13,2 ± 1.14 ng / l, aldosterone - 0.93 ± 0.07 nm / l, norepinephrine - 3.97 ± 0.31 nm / l, kallikrein - 9.8 ± 0.65 IU / ml, renin - 2, 48 ± 0.23 ng / ml h and statistically probable deviation of the measured values from the similar indices of patients with isolated COPD predict the formation of COPD. In this case, the formation of COPD in patients with GC may be previously predicted separately for each of the above indicators or for any set of measurements, provided that his / her compliance with certain levels and a statistically significant difference from the target measurements, followed by a refinement of the forecast for the entire set of declared measurements. |
| priorityDate | 2016-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.